Cargando…
Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole‐slide images
BACKGROUND: It is unclear whether clinical factors and immune microenvironment (IME) factors are associated with tumor mutation burden (TMB) in patients with nonsmall cell lung cancer (NSCLC). MATERIALS AND METHODS: We assessed TMB in surgical tumor specimens by performing whole exome sequencing. IM...
Autores principales: | Ono, Akira, Terada, Yukihiro, Kawata, Takuya, Serizawa, Masakuni, Isaka, Mitsuhiro, Kawabata, Takanori, Imai, Toru, Mori, Keita, Muramatsu, Koji, Hayashi, Isamu, Kenmotsu, Hirotsugu, Ohshima, Keiichi, Urakami, Kenichi, Nagashima, Takeshi, Kusuhara, Masatoshi, Akiyama, Yasuto, Sugino, Takashi, Ohde, Yasuhisa, Yamaguchi, Ken, Takahashi, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333844/ https://www.ncbi.nlm.nih.gov/pubmed/32400056 http://dx.doi.org/10.1002/cam4.3107 |
Ejemplares similares
-
Characterization of tumour mutation burden in patients with non‐small cell lung cancer and interstitial lung disease
por: Kobayashi, Haruki, et al.
Publicado: (2019) -
Tumor cell enrichment by tissue suspension enables detection of mutations with low variant allele frequency and estimation of germline mutations
por: Hatakeyama, Keiichi, et al.
Publicado: (2022) -
JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencing
por: Serizawa, Masakuni, et al.
Publicado: (2021) -
Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations
por: Hatakeyama, Keiichi, et al.
Publicado: (2018) -
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes
por: Ohnami, Sumiko, et al.
Publicado: (2022)